ArticlePharmaceutical research2022

Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera.

Richa Vartak et al.PubMed ↗Publisher ↗

No numbers read from the abstract.